1217456-98-8

Basic information

• Product Name: N6-(Aminoiminomethyl)-D-lysine hydrochloride
• Synonyms: N'-(Aminoiminomethyl)-D-lysine hydrochloride;N6-(Aminoiminomethyl)-D-lysine hydrochloride;D-HoMoArg-OH.HCl;(R)-2-AMino-6-guanidinohexanoic acid hydrochloride
• CAS NO: 1217456-98-8
• Molecular Formula: C7H16N4O2.HCl
• Molecular Weight: 225
• Mol File: 1217456-98-8.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: N6-(Aminoiminomethyl)-D-lysine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: N6-(Aminoiminomethyl)-D-lysine hydrochloride(1217456-98-8)
• EPA Substance Registry System: N6-(Aminoiminomethyl)-D-lysine hydrochloride(1217456-98-8)

Safety Data

• Hazardous Substances Data: 1217456-98-8(Hazardous Substances Data)

Usage

General Description

N6-(Aminoiminomethyl)-D-lysine hydrochloride, also known as ADMA, is a naturally occurring chemical in the body that is involved in the regulation of nitric oxide synthesis. It is a byproduct of protein methylation and is considered to be an endogenous inhibitor of nitric oxide synthase. ADMA has been implicated in various cardiovascular diseases, including hypertension, atherosclerosis, and heart failure, as it can lead to impaired endothelial function and increased oxidative stress. It is also a potential biomarker for renal disease and has been studied in the context of diabetes and neurodegenerative disorders. ADMA has potential implications for therapeutic interventions and may serve as a target for the development of new treatments for various diseases.